FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Battery Ventures IX, L.P. 		2. Issuer Name and Ticker or Trading Symbol

CHAMPIONS ONCOLOGY, INC. [ CSBR ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O BATTERY VENTURES, ONE MARINA PARK DRIVE, SUITE 1100 		3. Date of Earliest Transaction (MM/DD/YYYY)

1/8/2019
(Street)

BOSTON, MA 02210
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   1/8/2019     X    58333   A $4.80   2011882   (1) I   By Funds   (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant to purchase shares of Common Stock   $4.80   (3) (4) 1/18/2019     X      58333   (3) (4)      1/28/2013   1/27/2019   (3) Common Stock   58333   $0   0   I   By Funds   (2)

Explanation of Responses:
(1)  The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
(2)  Consists of 1,991,965 shares of the Issuer's Common Stock held by Battery Ventures IX, L.P. ("BVIX") and 19,917 shares of the Issuer's Common Stock held by Battery Investment Partners IX, LLC ("BIPIX"). Battery Partners IX, LLC ("BPIX") is the sole general partner of BVIX and the sole manager of BIPIX. Battery Management Corp. ("BMC") is the investment adviser of BPIX. Neeraj Agrawal, Michael M. Brown, Jesse Feldman, Roger H. Lee, R. David Tabors and Scott R. Tobin (collectively, the "Managing Members") are the managing members of BPIX. The Managing Members are also officers of BMC (collectively, the "Officers"). The Managing Members and the Officers, in their respective capacities as such, may be deemed to have shared voting and dispositive power over the shares held by BVIX and BIPIX.
(3)  Effective March 13, 2015, the warrants were amended to reduce the exercise price to $0.40 per share (before giving effect to the Reverse Stock Split referenced in footnote 4 below) and to change the expiration date to January 28, 2019.
(4)  Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Battery Ventures IX, L.P.
C/O BATTERY VENTURES
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210
X

Battery Investment Partners IX, LLC
C/O BATTERY VENTURES
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210
X

Battery Partners IX, LLC
C/O BATTERY VENTURES
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210
X

Battery Management Corp.
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210
X

Agrawal Neeraj
C/O BATTERY VENTURES
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210
X

BROWN MICHAEL MAURICE
C/O BATTERY VENTURES
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210
X

Feldman Jesse
C/O BATTERY VENTURES
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210
X

Lee Roger H
C/O BATTERY VENTURES
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210
X

TABORS R DAVID
C/O BATTERY VENTURES
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210
X

TOBIN SCOTT R
C/O BATTERY VENTURES
ONE MARINA PARK DRIVE, SUITE 1100
BOSTON, MA 02210 		X X


Signatures
/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of Battery Ventures IX, L.P.) 4/30/2019
** Signature of Reporting Person Date

/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of Battery Investment Partners IX, LLC) 4/30/2019
** Signature of Reporting Person Date

/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of Battery Partners IX, LLC) 4/30/2019
** Signature of Reporting Person Date

/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of Battery Management Corp.) 4/30/2019
** Signature of Reporting Person Date

/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of Neeraj Agrawal) 4/30/2019
** Signature of Reporting Person Date

/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of Michael M. Brown) 4/30/2019
** Signature of Reporting Person Date

/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of Jesse R. Feldman) 4/30/2019
** Signature of Reporting Person Date

/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of Roger H. Lee) 4/30/2019
** Signature of Reporting Person Date

/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of R. David Tabors) 4/30/2019
** Signature of Reporting Person Date

/s/ Christopher Schiavo (acting as attorney-in-fact on behalf of Scott R. Tobin) 4/30/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Champions Oncology (NASDAQ:CSBR)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Champions Oncology Charts.
Champions Oncology (NASDAQ:CSBR)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Champions Oncology Charts.